JY, H., F, F., I, L., F, P., M, D., P, L., . . . V, D. (2026). Prospective gait analysis in patients from the French registry of glycogen storage disease type III: Implications for clinical trials. Journal of neurology, 273(5), . https://doi.org/10.1007/s00415-026-13793-2
Chicago Style (17th ed.) CitationJY, Hogrel, et al. "Prospective Gait Analysis in Patients from the French Registry of Glycogen Storage Disease Type III: Implications for Clinical Trials." Journal of Neurology 273, no. 5 (2026). https://doi.org/10.1007/s00415-026-13793-2.
MLA (9th ed.) CitationJY, Hogrel, et al. "Prospective Gait Analysis in Patients from the French Registry of Glycogen Storage Disease Type III: Implications for Clinical Trials." Journal of Neurology, vol. 273, no. 5, 2026, https://doi.org/10.1007/s00415-026-13793-2.